Literature DB >> 32820163

Comorbid depression in medical diseases.

Stefan M Gold1,2,3, Ole Köhler-Forsberg4,5,6, Rona Moss-Morris7, Anja Mehnert8, J Jaime Miranda9, Monika Bullinger10, Andrew Steptoe11, Mary A Whooley12, Christian Otte13.   

Abstract

Depression is one of the most common comorbidities of many chronic medical diseases including cancer and cardiovascular, metabolic, inflammatory and neurological disorders. Indeed, the prevalence of depression in these patient groups is often substantially higher than in the general population, and depression accounts for a substantial part of the psychosocial burden of these disorders. Many factors can contribute to the occurrence of comorbid depression, such as shared genetic factors, converging biological pathways, social factors, health behaviours and psychological factors. Diagnosis of depression in patients with a medical disorder can be particularly challenging owing to symptomatic overlap. Although pharmacological and psychological treatments can be effective, adjustments may need to be made for patients with a comorbid medical disorder. In addition, symptoms or treatments of medical disorders may interfere with the treatment of depression. Conversely, symptoms of depression may decrease adherence to treatment of both disorders. Thus, comprehensive treatment plans are necessary to optimize care.

Entities:  

Mesh:

Year:  2020        PMID: 32820163     DOI: 10.1038/s41572-020-0200-2

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  45 in total

Review 1.  Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research.

Authors:  Kristen Davies; Emma Dures; Wan-Fai Ng
Journal:  Nat Rev Rheumatol       Date:  2021-10-01       Impact factor: 20.543

Review 2.  Multimorbidity.

Authors:  Søren T Skou; Frances S Mair; Martin Fortin; Bruce Guthrie; Bruno P Nunes; J Jaime Miranda; Cynthia M Boyd; Sanghamitra Pati; Sally Mtenga; Susan M Smith
Journal:  Nat Rev Dis Primers       Date:  2022-07-14       Impact factor: 65.038

3.  Pre-existing and new-onset depression among patients undergoing esophageal cancer surgery: a nationwide cohort study in South Korea.

Authors:  Tak Kyu Oh; In-Ae Song; Hye Yoon Park; Jung-Won Hwang
Journal:  Esophagus       Date:  2022-07-29       Impact factor: 3.671

4.  High-fat diet induces depression-like phenotype via astrocyte-mediated hyperactivation of ventral hippocampal glutamatergic afferents to the nucleus accumbens.

Authors:  Sheng-Feng Tsai; Pei-Ling Hsu; Yun-Wen Chen; Mohammad Shahadat Hossain; Pei-Chun Chen; Shun-Fen Tzeng; Po-See Chen; Yu-Min Kuo
Journal:  Mol Psychiatry       Date:  2022-09-30       Impact factor: 13.437

5.  Prefrontal-amygdala emotion regulation and depression in multiple sclerosis.

Authors:  Lil Meyer-Arndt; Joseph Kuchling; Jelena Brasanac; Andrea Hermann; Susanna Asseyer; Judith Bellmann-Strobl; Friedemann Paul; Stefan M Gold; Martin Weygandt
Journal:  Brain Commun       Date:  2022-06-13

Review 6.  Depression, aging, and immunity: implications for COVID-19 vaccine immunogenicity.

Authors:  Bart N Ford; Jonathan Savitz
Journal:  Immun Ageing       Date:  2022-07-14       Impact factor: 9.701

7.  Costs associated with depression and obesity among cardiovascular patients: medical expenditure panel survey analysis.

Authors:  Felipe Saia Tápias; Victor Henrique Oyamada Otani; Daniel Augusto Corrêa Vasques; Thais Zelia Santos Otani; Ricardo Riyoiti Uchida
Journal:  BMC Health Serv Res       Date:  2021-05-06       Impact factor: 2.655

8.  Chronic Pain and Mood Disorders in Asian Americans.

Authors:  Deborah L Huang; Indraneil Bardhan; Joohyun Shin; Jordan F Karp; Mijung Park
Journal:  Asian Pac Isl Nurs J       Date:  2021

9.  Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.

Authors:  Ricardo Araya; Paulo Rossi Menezes; Heloísa Garcia Claro; Lena R Brandt; Kate L Daley; Julieta Quayle; Francisco Diez-Canseco; Tim J Peters; Daniela Vera Cruz; Mauricio Toyama; Suzana Aschar; Liliana Hidalgo-Padilla; Hellen Martins; Victoria Cavero; Thais Rocha; George Scotton; Ivan F de Almeida Lopes; Mark Begale; David C Mohr; J Jaime Miranda
Journal:  JAMA       Date:  2021-05-11       Impact factor: 157.335

10.  Depression predictions from GPS-based mobility do not generalize well to large demographically heterogeneous samples.

Authors:  Sandrine R Müller; Xi Leslie Chen; Heinrich Peters; Augustin Chaintreau; Sandra C Matz
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.